enterprise value $100m - lani superior tamiflu, page-4

BTA still being shorted heavily.

27% of trades yesterday were fresh shorts.

I am now of the opinion that this shorting activity is being done with the blessing of management due to:
- lack of any announcements on patent grants/Relenza outlook/Lani/HRV progress/company valuation.
- lack of any director buying.

Now in this environment, it would not surprise me to see to see a new substantial holder being announced within a week or two.

I will wait and see. But I now wonder if by design?